Tech Company Financing Transactions
MiRagen Therapeutics Funding Round
MiRagen Therapeutics closed a $8.5 million financing round on 2/18/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
2/18/2015
Transaction Type
Debt
Amount
$8,499,962
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6200 Lookout Rd. 100
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Marshall
Chief Financial Officer
Jason Leverone
VP - Bus. Development
Christopher Morl
Browse more venture capital transactions:
Prev: 2/18/2015: Luxury Garage Sale venture capital transaction
Next: 2/18/2015: Axcient venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs